BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2757969)

  • 1. Relationship between the nicotinamide adenine dinucleotide redox potential and the 2,3-diphosphoglycerate content in the erythrocyte in sickle cell disease.
    Lachant NA; Zerez CR; Tanaka KR
    Br J Haematol; 1989 Jun; 72(2):265-71. PubMed ID: 2757969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.
    Zerez CR; Lachant NA; Lee SJ; Tanaka KR
    Blood; 1988 Feb; 71(2):512-5. PubMed ID: 3337912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
    Seakins M; Gibbs WN; Milner PF; Bertles JF
    J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.
    Poillon WN; Kim BC
    Blood; 1990 Sep; 76(5):1028-36. PubMed ID: 2393711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridine nucleotide redox potential in erythrocytes of saudi subjects with sickle cell disease.
    Al-Ali AK
    Acta Haematol; 2002; 108(1):19-22. PubMed ID: 12145462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential.
    Niihara Y; Zerez CR; Akiyama DS; Tanaka KR
    Am J Hematol; 1998 Jun; 58(2):117-21. PubMed ID: 9625578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content.
    Zerez CR; Lachant NA; Tanaka KR
    Blood; 1990 Sep; 76(5):1008-14. PubMed ID: 2393709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 31P NMR measurements of intracellular pH and 2,3-diphosphoglycerate in erythrocytes.
    Petersen A; Jacobsen JP; Hørder M
    Scand J Clin Lab Invest; 1987 May; 47(3):233-7. PubMed ID: 3589487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisickling effects of 2,3-diphosphoglycerate depletion.
    Poillon WN; Kim BC; Labotka RJ; Hicks CU; Kark JA
    Blood; 1995 Jun; 85(11):3289-96. PubMed ID: 7756662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxygenation permeabilizes sickle cell anaemia red cells to magnesium and reverses its gradient in the dense cells.
    Ortiz OE; Lew VL; Bookchin RM
    J Physiol; 1990 Aug; 427():211-26. PubMed ID: 2213597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of increasing the intracellular ratio of NADH to NAD+ on human erythrocyte metabolism: new estimation of the turnover through the phosphoglycerate shunt.
    Momsen G
    Arch Biochem Biophys; 1981 Aug; 210(1):160-6. PubMed ID: 7294824
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of erythrocyte membrane mechanical stability by 2,3-diphosphoglycerate in the neonatal poikilocytosis/elliptocytosis syndrome.
    Mentzer WC; Iarocci TA; Mohandas N; Lane PA; Smith B; Lazerson J; Hays T
    J Clin Invest; 1987 Mar; 79(3):943-9. PubMed ID: 3818955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study].
    Briguglio F; Briguglio E; Di Marco V
    Minerva Med; 1986 Feb; 77(7-8):249-62. PubMed ID: 3951731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S.
    Poillon WN; Kim BC; Welty EV; Walder JA
    Arch Biochem Biophys; 1986 Sep; 249(2):301-5. PubMed ID: 3753004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of hemoglobin in human red cells. I. Oxygen equilibrium curves and DPG binding.
    Girard F; Kister J; Bohn B; Poyart C
    Respir Physiol; 1987 May; 68(2):227-38. PubMed ID: 3602619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-term strenuous exercise on erythrocyte 2,3-diphosphoglycerate in untrained men: a time-course study.
    Odje OE; Ramsey JM
    Eur J Appl Physiol Occup Physiol; 1995; 71(1):53-7. PubMed ID: 7556132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nortestosterone decanoate on red cell 2,3 diphosphoglycerate and hematocrit in hemodialysis patients.
    Goodman J; Bessman AN
    Clin Pharmacol Ther; 1975 Feb; 17(2):167-70. PubMed ID: 1122676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen transport in congenital heart disease: influence of fetal hemoglobin, red cell pH, and 2,3-diphosphoglycerate.
    Versmold HT; Linderkamp C; Döhlemann C; Riegel KP
    Pediatr Res; 1976 Jun; 10(6):566-70. PubMed ID: 5699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.